THTX vs. LPCN, DRRX, VIRX, IPA, DARE, APLM, APRE, ACXP, ENLV, and NNVC
Should you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include Lipocine (LPCN), DURECT (DRRX), Viracta Therapeutics (VIRX), ImmunoPrecise Antibodies (IPA), Daré Bioscience (DARE), Apollomics (APLM), Aprea Therapeutics (APRE), Acurx Pharmaceuticals (ACXP), Enlivex Therapeutics (ENLV), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical preparations" industry.
Theratechnologies (NASDAQ:THTX) and Lipocine (NASDAQ:LPCN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.
In the previous week, Lipocine had 3 more articles in the media than Theratechnologies. MarketBeat recorded 6 mentions for Lipocine and 3 mentions for Theratechnologies. Theratechnologies' average media sentiment score of 0.96 beat Lipocine's score of 0.66 indicating that Theratechnologies is being referred to more favorably in the media.
Lipocine has lower revenue, but higher earnings than Theratechnologies. Lipocine is trading at a lower price-to-earnings ratio than Theratechnologies, indicating that it is currently the more affordable of the two stocks.
Lipocine has a net margin of 0.00% compared to Theratechnologies' net margin of -23.04%. Theratechnologies' return on equity of 0.00% beat Lipocine's return on equity.
9.1% of Lipocine shares are owned by institutional investors. 6.1% of Lipocine shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Theratechnologies has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Comparatively, Lipocine has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
Lipocine received 314 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 70.14% of users gave Lipocine an outperform vote while only 52.73% of users gave Theratechnologies an outperform vote.
Summary
Theratechnologies and Lipocine tied by winning 8 of the 16 factors compared between the two stocks.
Get Theratechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding THTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Theratechnologies Competitors List
Related Companies and Tools
